4//SEC Filing
Moglia Stephen A. 4
Accession 0001123292-18-000543
CIK 0001382911other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:20 PM ET
Size
4.5 KB
Accession
0001123292-18-000543
Insider Transaction Report
Form 4
Moglia Stephen A.
VP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2018-03-15$0.24/sh−1,694$407→ 0 total
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeother
Related Parties
1- filerCIK 0001665527
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:20 PM ET
- Size
- 4.5 KB